Compare UXIN & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UXIN | PROF |
|---|---|---|
| Founded | 2011 | N/A |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.0M | 248.8M |
| IPO Year | 2018 | 2017 |
| Metric | UXIN | PROF |
|---|---|---|
| Price | $1.14 | $7.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $11.14 |
| AVG Volume (30 Days) | ★ 421.9K | 233.6K |
| Earning Date | 09-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | $59.68 | $71.10 |
| Revenue Next Year | $71.25 | $58.54 |
| P/E Ratio | $4.05 | ★ N/A |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $0.90 | $4.91 |
| 52 Week High | $4.18 | $8.95 |
| Indicator | UXIN | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 66.78 |
| Support Level | $1.07 | $6.51 |
| Resistance Level | $1.27 | $7.92 |
| Average True Range (ATR) | 0.12 | 0.38 |
| MACD | -0.01 | 0.19 |
| Stochastic Oscillator | 17.07 | 93.33 |
Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates a car retailer, pioneering industry transformation with production, new retail experiences, and digital empowerment in China. With its inventory-owning model, it provides customers a comprehensive transaction solution that encompasses the entire value chain, ranging from used-car acquisition, inspection, and reconditioning, warehousing, as well as pre-sales and after-sales services. The group offers high-quality and value-for-money used cars as well as superior full suites of services to customers through a reliable, one-stop, and hassle-free transaction experience. It derives revenues from retail vehicle sales, wholesale vehicle sales, and other businesses. The Group generates its revenues in China.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.